This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Apr;58(4):330-1.

doi: 10.1001/archpsyc.58.4.330.

Cannabinoid antagonists: a treatment in search of an illness

D C D'Souza¹, T R Kosten

Affiliations

PMID: 11296092
DOI: 10.1001/archpsyc.58.4.330

Comment

Cannabinoid antagonists: a treatment in search of an illness

D C D'Souza et al. Arch Gen Psychiatry. 2001 Apr.

. 2001 Apr;58(4):330-1.

doi: 10.1001/archpsyc.58.4.330.

Authors

D C D'Souza¹, T R Kosten

Affiliation

¹ Department of Psychiatry, 151D, VA Connecticut Healthcare System, 950 Campbell Ave, Bldg 35, West Haven, CT 06516, USA. thomas.kosten@yale.edu

PMID: 11296092
DOI: 10.1001/archpsyc.58.4.330

No abstract available

PubMed Disclaimer

Comment on

Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.
Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA. Huestis MA, et al. Arch Gen Psychiatry. 2001 Apr;58(4):322-8. doi: 10.1001/archpsyc.58.4.322. Arch Gen Psychiatry. 2001. PMID: 11296091 Clinical Trial.

Similar articles

Getting stoned without inhaling: anandamide is the brain's natural marijuana.
Stahl SM. Stahl SM. J Clin Psychiatry. 1998 Nov;59(11):566-7. doi: 10.4088/jcp.v59n1101. J Clin Psychiatry. 1998. PMID: 9862600 No abstract available.
Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
Lay L, Angus JA, Wright CE. Lay L, et al. Eur J Pharmacol. 2000 Mar 10;391(1-2):151-61. doi: 10.1016/s0014-2999(00)00062-5. Eur J Pharmacol. 2000. PMID: 10720647
Endocannabinoids control spasticity in a multiple sclerosis model.
Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Makriyannis A, Khanolkar A, Layward L, Fezza F, Bisogno T, Di Marzo V. Baker D, et al. FASEB J. 2001 Feb;15(2):300-2. doi: 10.1096/fj.00-0399fje. Epub 2000 Dec 8. FASEB J. 2001. PMID: 11156943
[Cannabinoids, cannabinoid receptor and immune response].
Yan MS, Lian ML, Huang JS. Yan MS, et al. Sheng Li Ke Xue Jin Zhan. 2000 Jul;31(3):261-4. Sheng Li Ke Xue Jin Zhan. 2000. PMID: 12545719 Review. Chinese. No abstract available.
[Endocannabinoids--the new option in the treatment of metabolic syndrome and in smoking cessation].
Kvasnicka T. Kvasnicka T. Cas Lek Cesk. 2005;144(2):81-4; discussion 85. Cas Lek Cesk. 2005. PMID: 15807291 Review. Czech.

See all similar articles

Cited by

Modulation of fear and anxiety by the endogenous cannabinoid system.
Chhatwal JP, Ressler KJ. Chhatwal JP, et al. CNS Spectr. 2007 Mar;12(3):211-20. doi: 10.1017/s1092852900020939. CNS Spectr. 2007. PMID: 17329982 Free PMC article. Review.
Psychiatric morbidity of cannabis abuse.
Sarkar J, Murthy P, Singh SP. Sarkar J, et al. Indian J Psychiatry. 2003 Jul;45(3):182-8. Indian J Psychiatry. 2003. PMID: 21206852 Free PMC article.
Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health.
Bukke VN, Archana M, Villani R, Serviddio G, Cassano T. Bukke VN, et al. Pharmaceuticals (Basel). 2021 Sep 24;14(10):965. doi: 10.3390/ph14100965. Pharmaceuticals (Basel). 2021. PMID: 34681189 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information